From July 2019 the National Disability Insurance Scheme (NDIS) will be introducing its Quality and Safeguarding Framework (QSF) into Tasmania via the NDIS Quality and Safeguards Commission. The Commission will bring a nationally consistent approach to the reduction and elimination of the use of restrictive practices including a set of definitions for seclusion, physical restraint, mechanical restraint, environmental restraint and chemical restraint. Chemical Restraint will be defined as:‘the use of medication or chemical substance for the primary purpose of influencing a person’s behaviour or movement. It does not include the use of medication prescribed by a medical practitioner for the treatment of, or to enable treatment, of a diagnosed mental disorder, a physical illness or physical condition.
The NDIS Quality and Safeguards Commission will require registered service providers to report to them any use of a regulated restrictive practice. The service provider will also need to arrange for a behaviour support plan to be developed for the person being subject to a restrictive practice.
The Office of the Senior Practitioner has developed this resource to assist registered service providers determine the purpose of prescribed medication in conjunction with the medical practitioner so they can fulfil their reporting obligations to the NDIS Commission.
Registered service providers may therefore seek medical advice to understand whether a medication is prescribed to treat a physical condition, a mental illness or for behaviour management.
Medical practitioners are encouraged to complete the attached form during the patient’s visit when requested by the disability service provider. The form supports a patient’s current treatment sheet and does not replace it or any other reporting requirements.
Registered service providers do not require medical practitioners to state whether a medication is chemical restraint, only to explain the reason the medication is prescribed. Please refer to the Fact Sheet ‘Is this Chemical Restraint?’ to help guide this process.
Some examples of chemical restraint
It is important to note that the use of medication to control a person’s behaviour maybe the best current option, particularly in the short term or in instances where significant harm to the patient and others is likely. Administration of such medication in these situations ‘buys time’ for the development of a positive behaviour support plan and the implementation of strategies that may then allow medical practitioners to safely reduce and cease the patient’s medication use if it has been prescribed for behaviour modification purposes.
Medications are regarded as a chemical restraint if they are being used to change or modify someone’s behaviour and are prescribed:
- without a diagnosis of a disorder of physical or mental health for which the medication is indicated. For example:
- psychotropic medication prescribed when the patient does not have a mental health diagnosis;
- for symptomatic treatment without an underlying diagnosis.
As is the case with all medication administration, the support approach adopted needs to be tailored to the individual. It is best practice to seek advice from the prescribing doctor regarding the medication being prescribed, enquiring if other therapies could compliment or work in conjunction with the medication to help the person to develop new skills or for adaptations to be made within that person’s environment in order to support them in a more positive manner. Different approaches may be more appropriate or useful for different concerns and should be explored taking into account the unique considerations for that individual.
Further examples of chemical restraint that may affect your patient include:
- menstruation suppression: A disability service considers the woman unable to manage her period and the service uses contraceptive devices to suppress the woman’s menstrual cycle. This is not the least restrictive way of supporting a woman with a disability to manage her menstrual cycle.
Requirements of disability staff in relation to healthcare and behaviour management
The diagram below demonstrates the different planning and reporting best practice approaches of disability service providers in relation to:
- meeting the healthcare of the people they support
- managing the person’s behaviour.
Diagram of reporting responsibilities of disability service providers
Physical conditions require a health management plan, which is reviewed 3 monthly and updated within 12 months. Epilepsy plans must be reviewed and updated within 12 months.
Mental health conditions require a mental health management plan, which is reviewed and updated within 12 months. Health management plans, epilepsy plans and mental health management plans must be signed by the treating medical practitioner.
Behaviour management requires a behaviour support plan with monthly reporting to the Senior Practitioner and updated within 12 months.
Mental health and behaviour management requires a mental health management plan and a behaviour support plan.
* Mental health diagnosis – not all mental health diagnoses are indications for medication. For example, the diagnosis of Autism Spectrum Disorder describes the functional difficulties someone may have in their life but is not, in itself, an indication for medication.
^ Epilepsy management plans have a separate reporting form from other physical condition management plans.
# The behaviour support plan must describe how any person who is subjected to restrictive practice will be supported and show that the restrictive practice is used are the least restrictive option and are only being used as a last resort. Medication used to modify behaviour, without a diagnostic indication, is defined as a restrictive practice and requires reporting and the development of a comprehensive behaviour support plan.
 NDIS (Restrictive Practices and Behaviour Support) Rules 2018
How do I contact the Senior Practitioner?
The Senior Practitioner is available to discuss any issues or concerns relating to the use or potential use of a restrictive intervention on the contact details listed below.
Telephone: (03) 6166 3567
Mobile: 0428 197 474
Find out more about Chemical Restraint using the RISET-Tas:
Access practice resources and restrictive intervention information via RISET-TAS online: RISET-Tas